Michael V. Seiden

No ORCID on file · 2 papers in corpus

nonrandomized-trial 2012

The FACIT-AI, a new tool for assessing symptoms associated with malignant ascites

Gynecologic Oncology ·doi:10.1016/j.ygyno.2012.11.013

OBJECTIVE: The objectives of this study are to assess the clinical relevance and validity of the Functional Assessment of Chronic Illness Therapy-Ascites Index (FACIT-AI) in women with ovarian cancer and malignant ascites, and to modify the…

case-report 2006

Reclassification of a tubal leiomyosarcoma as an eGIST by molecular evaluation of c-KIT

Gynecologic Oncology ·doi:10.1016/j.ygyno.2005.12.022

BACKGROUND: Extragastrointestinal stromal tumors (eGISTs) are rare mesenchymal-derived tumors arising outside of the GI tract. eGISTs are often histologically confused with leiomyosarcoma. Distinction between eGIST and leiomyosarcoma is cri…